Stay updated on Nusinersen Safety in SMA Clinical Trial
Sign up to get notified when there's something new on the Nusinersen Safety in SMA Clinical Trial page.

Latest updates to the Nusinersen Safety in SMA Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows a new revision label 'Revision: v3.3.4' and removes the previous 'Revision: v3.3.3'. There are no observed changes to core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA consolidated Locations section is added, listing sites in California, Connecticut, Maryland, Minnesota, Texas, and Washington, while individual state location headings were removed. The page revision updated to version 3.3.3.SummaryDifference0.7%

- Check51 days agoChange DetectedMinor editorial updates were added: a PubMed auto-fill note indicating publications may be sourced from PubMed and the revision label updated to v3.3.2, while the older wording and revision v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedA general government funding/operating status banner was removed from the page. The study title, design, eligibility criteria, contacts, and locations remain unchanged.SummaryDifference0.3%

- Check72 days agoChange DetectedNo substantial changes were detected in the study details, design, eligibility criteria, or outcomes; the update appears to be minor formatting adjustments and a revised timestamp.SummaryDifference0.4%

- Check101 days agoChange Detected- Added new topic: Spinal muscular atrophy and updated to revision v3.2.0. - Removed specific term: Proximal spinal muscular atrophy and previous revision v3.1.0.SummaryDifference2%

Stay in the know with updates to Nusinersen Safety in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nusinersen Safety in SMA Clinical Trial page.